"The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on Monday, July 11, 2016. Xiidra is the first medication in a new class of drugs, called lymphocyt"...
Restasis Patient Information Including Side Effects
Brand Names: Restasis
Generic Name: cyclosporine ophthalmic (Pronunciation: SYE kloe SPOR een off THAL mik)
- What is cyclosporine ophthalmic (Restasis)?
- What are the possible side effects of cyclosporine ophthalmic (Restasis)?
- What is the most important information I should know about cyclosporine ophthalmic (Restasis)?
- What should I discuss with my healthcare provider before using cyclosporine ophthalmic (Restasis)?
- How should I use cyclosporine ophthalmic (Restasis)?
- What happens if I miss a dose (Restasis)?
- What happens if I overdose (Restasis)?
- What should I avoid while using cyclosporine ophthalmic (Restasis)?
- What other drugs will affect cyclosporine ophthalmic (Restasis)?
- Where can I get more information?
What is cyclosporine ophthalmic (Restasis)?
Cyclosporine is an immunosuppressive agent. Cyclosporine ophthalmic may reduce inflammation in the eye(s).
Cyclosporine ophthalmic is used to treat chronic dry eye that may be caused by inflammation.
Cyclosporine ophthalmic may also be used for purposes other than those listed in this medication guide.
What are the possible side effects of cyclosporine ophthalmic (Restasis)?
Serious side effects are not expected to occur during treatment with this medication.
Eye burning, redness, tearing, discharge, pain, itching, stinging, or visual blurring may occur.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the Restasis (cyclosporine) Side Effects Center for a complete guide to possible side effects
What is the most important information I should know about cyclosporine ophthalmic (Restasis)?
Do not touch the dropper to any surface, including the eyes or hands. The dropper is sterile. If it becomes contaminated, it could cause an infection in the eye(s).
Do not use cyclosporine ophthalmic while wearing contact lenses. Contact lenses may be reinserted 15 minutes following administration of cyclosporine ophthalmic, unless otherwise directed by your doctor.
Additional Restasis Information
- Restasis Drug Interactions Center: cyclosporine opht
- Restasis Side Effects Center
- Restasis Overview including Precautions
- Restasis FDA Approved Prescribing Information including Dosage
Restasis - User Reviews
Restasis User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.